🔗 Permalink

Inventor profile of:

Bryan D. LEMON

City:

Mountain View, California

Country:

United States

Published Applications:

Last publication date:

2026-04-23

Top Assignees for applications by Bryan D. LEMON

The entities that hold a legal rights for patent applications filed by inventor LEMON Bryan D.:

Harpoon Therapeutics, Inc. 15 South San Francisco, CA United States
Harpoon Therapeutics, Inc. 2 Rahway, NJ United States
TCR2 THERAPEUTICS INC. 1 Cambridge, MA United States

Recent patent applications by LEMON Bryan D.

Bryan D. LEMON from Mountain View, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-04-23

US20260109773A1

Chemistry; metallurgy

TRISPECIFIC PROTEINS AND METHODS OF USE

#2 | 2024-10-10

US20240336909A1

Chemistry; metallurgy

CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

#3 | 2024-10-03

US20240327534A1

Chemistry; metallurgy

B CELL MATURATION ANTIGEN BINDING PROTEINS

#4 | 2024-07-11

US20240228656A1

Chemistry; metallurgy

EPCAM TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER

#5 | 2024-07-04

US20240216518A1

Human necessities

EXTENDED-RELEASE IMMUNE CELL ENGAGING PROTEINS AND METHODS OF TREATMENT

#6 | 2024-03-28

US20240100157A1

Human necessities

MESOTHELIN BINDING PROTEINS

#7 | 2024-03-14

US20240084035A1

Chemistry; metallurgy

COMBINATION THERAPY WITH IMMUNE CELL ENGAGING PROTEINS AND IMMUNOMODULATORS

#8 | 2023-08-17

US20230257451A1

Chemistry; metallurgy

SINGLE DOMAIN SERUM ALBUMIN BINDING PROTEIN

#9 | 2022-04-14

US20220112297A1

Chemistry; metallurgy

TRISPECIFIC PROTEINS AND METHODS OF USE

#10 | 2022-02-24

US20220054544A1

Human necessities

CONDITIONALLY ACTIVE RECEPTORS

#11 | 2021-09-23

US20210292421A1

Chemistry; metallurgy

BINDING MOIETY FOR CONDITIONAL ACTIVATION OF IMMUNOGLOBULIN MOLECULES

#12 | 2021-09-16

US20210284728A1

Chemistry; metallurgy

DUAL BINDING MOIETY

#13 | 2021-09-02

US20210269530A1

Chemistry; metallurgy

CONDITIONALLY ACTIVATED BINDING PROTEIN COMPRISING A STERICALLY OCCLUDED TARGET BINDING DOMAIN

#14 | 2021-06-10

US20210171649A1

Chemistry; metallurgy

B cell maturation antigen binding proteins

#15 | 2021-04-08

US20210100902A1

Human necessities

PROSTATE SPECIFIC MEMBRANE ANTIGEN BINDING PROTEIN

#16 | 2021-04-01

US20210095047A1

Chemistry; metallurgy

PSMA Targeting Trispecific Proteins and Methods of Use

#17 | 2020-11-19

US20200362306A1

Chemistry; metallurgy

Compositions and methods for TCR reprogramming using fusion proteins

#18 | 2020-09-17

US20200289646A1

Human necessities

Mesothelin binding proteins

#19 | 2020-08-27

US20200270362A1

Chemistry; metallurgy

MSLN TARGETING TRISPECIFIC PROTEINS AND METHODS OF USE

#20 | 2019-05-09

US20190135930A1

Chemistry; metallurgy

B cell maturation antigen binding proteins

#21 | 2019-04-18

US20190112381A1

Chemistry; metallurgy

Trispecific proteins and methods of use

#22 | 2019-01-31

US20190031749A1

Chemistry; metallurgy

Single domain serum albumin binding protein

#23 | 2018-11-15

US20180327508A1

Chemistry; metallurgy

MSLN targeting trispecific proteins and methods of use

#24 | 2018-11-15

US20180326060A1

Human necessities

Mesothelin binding proteins

#25 | 2018-06-14

US20180162949A1

Chemistry; metallurgy

PSMA targeting trispecific proteins and methods of use

#26 | 2018-06-14

US20180161428A1

Human necessities

Prostate specific membrane antigen binding protein

#27 | 2017-12-28

US20170369575A1

Chemistry; metallurgy

Single chain variable fragment CD3 binding proteins

#28 | 2017-12-28

US20170369563A1

Chemistry; metallurgy

Single domain serum albumin binding protein

#29 | 2017-11-23

US20170334997A1

Chemistry; metallurgy

Single chain variable fragment CD3 binding proteins

#30 | 2017-11-23

US20170334979A1

Chemistry; metallurgy

Single domain serum albumin binding protein

InventorID:

2044489 ⎘